1ADAdAlta1AD info
$0.01info0.00%24h
Global rank
Market cap$0
Change 7d0.00%
YTD Performance-32.00%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Category
Business data

    AdAlta (1AD) Stock Overview

    AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics by its i-body platform in Australia. Its lead product is AD-214, an antibody therapeutic, which is in Phase I clinical trial for the treatment of fibrotic diseases, including idiopathic pulmonary fibrosis and interstitial lung disease, kidney fibrosis, eye fibrosis, and various cancers. AdAlta Limited has collaborative partnerships with GE Healthcare to develop i-body enabled granzyme B PET imaging agents for use in immuno-oncology; and Carina Biotech to develop CAR-T cell products against various solid tumor antigens. The company was incorporated in 2006 and is based in Bundoora, Australia.

    1AD Stock Information

    Symbol
    1AD
    Address
    2 Park DriveBundoora, VIC 3083Australia
    Founded
    -
    Trading hours
    -
    Website
    https://www.adalta.com.au
    Country
    🇦🇺 Australia
    Phone Number
    61 3 9479 5159

    AdAlta (1AD) Price Chart

    -
    Value:-

    AdAlta Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.010830370908349578
    N/A
    Market Cap
    $0
    N/A
    Employees
    10.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org